Page 993 - Read Online

Page 14 of 18 Machado. Hepatoma Res 2020;6:84 I http://dx.doi.org/10.20517/2394-5079.2020.90

19. Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med
2000;132:112-7.
20. Feng RN, Du SS, Wang C, et al. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese
population. World J Gastroenterol 2014;20:17932-40.
21. Nishioji K, Sumida Y, Kamaguchi M, et al. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese
population, 2011-2012. J Gastroenterol 2015;50:95-108.
22. Wei JL, Leung JC, Loong TC, et al. Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study
using proton-magnetic resonance spectroscopy. Am J Gastroenterol 2015;110:1306-14; quiz 15.
23. Kim SS, Cho HJ, Kim HJ, et al. Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-
obese subjects. Dig Liver Dis 2018;50:370-7.
24. Sinn DH, Kang D, Cho SJ, et al. Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study. Eur J Endocrinol
2019;181:185-92.
25. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of
ethnicity. Hepatology 2004;40:1387-95.
26. Alberti KG, Zimmet P, Shaw J, Group IDFETFC. The metabolic syndrome--a new worldwide definition. Lancet 2005;366:1059-62.
27. Sookoian S, Pirola CJ. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered
metabolic and cardiovascular profile between lean and obese patients. Aliment Pharmacol Ther 2017;46:85-95.
28. Feldman A, Eder SK, Felder TK, et al. Clinical and metabolic characterization of lean caucasian subjects with non-alcoholic fatty liver.
Am J Gastroenterol 2017;112:102-10.
29. Margariti E, Deutsch M, Manolakopoulos S, Papatheodoridis GV. Non-alcoholic fatty liver disease may develop in individuals with
normal body mass index. Ann Gastroenterol 2012;25:45-51.
30. Kumar R, Rastogi A, Sharma MK, et al. Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease
in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fatty liver disease? Indian J
Endocrinol Metab 2013;17:665-71.
31. Kwon YM, Oh SW, Hwang SS, Lee C, Kwon H, Chung GE. Association of nonalcoholic fatty liver disease with components of metabolic
syndrome according to body mass index in Korean adults. Am J Gastroenterol 2012;107:1852-8.
32. Xu C, Yu C, Ma H, Xu L, Miao M, Li Y. Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese
Chinese population: the Zhejiang Zhenhai Study. Am J Gastroenterol 2013;108:1299-304.
33. Kim NH, Kim JH, Kim YJ, et al. Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver
disease in nonobese subjects. Liver Int 2014;34:604-11.
34. Wong VW, Wong GL, Yeung DK, et al. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired
proton-magnetic resonance spectroscopy. J Hepatol 2015;62:182-9.
35. Niriella MA, Kasturiratne A, Pathmeswaran A, et al. Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic
outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka. Hepatol Int 2019;13:314-22.
36. Li L, Liu DW, Yan HY, Wang ZY, Zhao SH, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence
from a meta-analysis of 21 cohort studies. Obes Rev 2016;17:510-9.
37. Kumar R, Mohan S. Non-alcoholic fatty liver disease in lean subjects: characteristics and implications. J Clin Transl Hepatol
2017;5:216-23.
38. Bernhardt P, Kratzer W, Schmidberger J, Graeter T, Gruener B, Group ES. Laboratory parameters in lean NAFLD: comparison of subjects
with lean NAFLD with obese subjects without hepatic steatosis. BMC Res Notes 2018;11:101.
39. Younes R, Bugianesi E. NASH in Lean Individuals. Semin Liver Dis 2019;39:86-95.
40. Trepo E, Valenti L. Update on NAFLD genetics: from new variants to the clinic. J Hepatol 2020;72:1196-209.
41. Adams LC, Lubbe F, Bressem K, Wagner M, Hamm B, Makowski MR. Non-alcoholic fatty liver disease in underweight patients with
inflammatory bowel disease: a case-control study. PLoS One 2018;13:e0206450.
42. Buchman AL, Naini BV, Spilker B. The differentiation of intestinal-failure-associated liver disease from nonalcoholic fatty liver and
nonalcoholic steatohepatitis. Semin Liver Dis 2017;37:33-44.
43. Duarte SMB, Stefano JT, Miele L, et al. Gut microbiome composition in lean patients with NASH is associated with liver damage
independent of caloric intake: a prospective pilot study. Nutr Metab Cardiovasc Dis 2018;28:369-84.
44. Yildiz Y, Sivri HS. Inborn errors of metabolism in the differential diagnosis of fatty liver disease. Turk J Gastroenterol 2020;31:3-16.
45. Machado MV, Diehl AM. Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology 2016;150:1769-77.
46. Ruderman NB, Schneider SH, Berchtold P. The “metabolically-obese” normal-weight individual. Am J Clin Nutr 1981;34:1617-21.
47. Stefan N, Schick F, Haring HU. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell
Metab 2017;26:292-300.
48. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and
meta-analysis. Ann Intern Med 2013;159:758-69.
49. Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes (Lond) 2008;32 Suppl 3:S56-9.
50. Gujral UP, Vittinghoff E, Mongraw-Chaffin M, et al. Cardiometabolic abnormalities among normal-weight persons from five racial/
Ethnic Groups in the United States: a cross-sectional analysis of two cohort studies. Ann Intern Med 2017;166:628-36.
51. Wang B, Zhuang R, Luo X, et al. Prevalence of metabolically healthy obese and metabolically obese but normal weight in adults
worldwide: a meta-analysis. Horm Metab Res 2015;47:839-45.